Heartflow, Inc. (HTFL)
$50.20+0.90%Close
BUYRECOVERY · day 18
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $4.3B
- Avg volume
- 1.6M
- Beta
- 2.02
- P/E (TTM)
- -35.63
- Short % float
- 10.32%
- Days to cover
- 6.6
- SI change
- +16.6%
- 1W
- +19.69%
- 1M
- +108.13%
- 3M
- +70.23%
- YTD
- +73.28%
- vs SPY 1W
- +20.89%
- vs SPY 1M
- +104.81%
- vs SPY 3M
- +67.84%
- vs SPY YTD
- +61.53%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AKTSBUYAktis Oncology, Inc.Q 31$25.98+7.94%
- CTKBBUYCytek Biosciences, Inc.RECOVERYQ -10$4.44-7.69%
- IMCRBUYImmunocore Holdings plcRECOVERYQ 5$36.61-0.73%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -12$0.72+0.00%
- APVOBUYAptevo Therapeutics Inc.CRISISQ -28$2.41-10.07%
- GANXBUYGain Therapeutics, Inc.RECOVERYQ -12$2.00-0.50%
- ZNTLSELLZentalis Pharmaceuticals, Inc.CRISISQ -5$3.76-1.83%
- SNYRSELLSynergy CHC Corp.CRISISQ 1$0.10+0.00%
- COSMSELLCosmos Health Inc.RECOVERYQ -3$0.21-4.55%
- MENSSELLJyong Biotech Ltd. Ordinary SharesRECOVERYQ -30$2.22+1.83%
- DCOYSELLDecoy Therapeutics Inc.CRISISQ -24$3.11-2.81%
- KPRXBUYKiora Pharmaceuticals, Inc.RECOVERYQ -16$2.75+3.38%
Industry peers
FMP comparable companies · ranked by market cap
- TVTXBUYTravere Therapeutics, Inc.$5.9BBULLQ 34$63.90-0.75%
- LIVNSELLLivaNova PLC$4.4BBEARQ 3$79.86-0.61%
- LEGNBUYLegend Biotech Corporation$4.1BRECOVERYQ 4$21.92-4.03%
- IRONBUYDisc Medicine, Inc.$3.1BRECOVERYQ 4$80.20+1.42%
- TARSBUYTarsus Pharmaceuticals, Inc.$3.1BRECOVERYQ 24$71.03+0.15%
- ZLABBUYZai Lab Limited$2.9BRECOVERYQ 9$25.57-1.42%
- PRVASELLPrivia Health Group, Inc.$2.7BCRISISQ 13$21.52-0.47%
- SGRYSELLSurgery Partners, Inc.$1.9BCRISISQ 7$14.24-3.93%
- PRGOBUYPerrigo Company plc$1.8BRECOVERYQ 1$12.97+0.14%
- ATECBUYAlphatec Holdings, Inc.$1.5BRECOVERYQ -1$9.53-2.53%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 8
- GROWTH
- 19
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-25.4%
REV YoY-
ROE-42.3%
EPS YoY-
ROA-34.4%
GROSS80
OP-34
NET-56
[VALUATION]
P/E TTM-35.63
P/E FWD-
SECTOR PE22.62
INDUSTRY PE28.11
P/B15.63
P/FCF-
EV/EBITDA-40.04
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E9.70
ALTMAN Z-
CURR RATIO5.08
ND/EBITDA-
BETA2.02
